New Ebola Vaccine Is ‘Highly Effective’
VSV-ZEBOV was originally developed by Canada’s public health agency before being licensed to NewLink Genetics, which then signed a deal handing Merck the responsibility to research, develop, manufacture and distribute it.
Posted On Aug 15 2015